1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key Market
Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Region
5.8. Clinical Trials Heat
Map
6.
Global Penicillin Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value &
Volume
6.2. Market Share &
Forecast
6.2.1. By Product (Bulk, Dosage)
6.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin,
Beta Lactamase Inhibitor, Others)
6.2.3. By Route of Administration (Oral, Intramuscular,
Intravenous)
6.2.4. By End User (Hospitals & Clinics, Pharmaceutical
& Biotechnology Companies, Academic & Research Institutions)
6.2.5. By Region (North America, Europe, Asia Pacific, South
America, Middle East & Africa)
6.2.6. By Company (2022)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7.
North America Penicillin Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value &
Volume
7.2. Market Share &
Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States Penicillin
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value & Volume
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Type
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By End User
7.3.2. Canada Penicillin Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value & Volume
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Type
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By End User
7.3.3. Mexico Penicillin Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value & Volume
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Type
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By End User
8.
Europe Penicillin Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value &
Volume
8.2. Market Share &
Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. France Penicillin Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value & Volume
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Type
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By End User
8.3.2. Germany Penicillin Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value & Volume
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Type
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By End User
8.3.3. United Kingdom Penicillin
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value & Volume
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Type
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By End User
8.3.4. Italy Penicillin Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value & Volume
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Type
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By End User
8.3.5. Spain Penicillin Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value & Volume
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Type
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By End User
9.
Asia-Pacific Penicillin Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value &
Volume
9.2. Market Share &
Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Penicillin Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value & Volume
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Type
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By End User
9.3.2. India Penicillin Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value & Volume
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Type
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By End User
9.3.3. Japan Penicillin Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value & Volume
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Type
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By End User
9.3.4. South Korea Penicillin
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value & Volume
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Type
9.3.4.2.3.
By Route of Administration
9.3.4.2.4.
By End User
9.3.5. Australia Penicillin
Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value & Volume
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product
9.3.5.2.2.
By Type
9.3.5.2.3.
By Route of Administration
9.3.5.2.4.
By End User
10.
South America Penicillin Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Penicillin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Type
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By End User
10.3.2. Argentina Penicillin
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Type
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By End User
10.3.3. Colombia Penicillin Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Type
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By End User
11.
Middle East and Africa Penicillin Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value &
Volume
11.2.
Market Share & Forecast
11.2.1. By Product
11.2.2. By Type
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Penicillin
Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Type
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By End User
11.3.2. Saudi Arabia Penicillin
Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Type
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By End User
11.3.3. UAE Penicillin Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Type
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By End User
12. Market Dynamics
12.1.
Drivers
12.1.1. Growing Prevalence of Infectious Diseases
12.1.2. Rise in Research & Development Activities
12.1.3. Supportive Government Policies & Initiatives
12.2.
Challenges
12.2.1. Development of Antibacterial Resistance
12.2.2. Stringent Regulatory Scenario
13. Market Trends &
Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Launches
14. Global Penicillin
Market: SWOT Analysis
15. Competitive Landscape
15.1.
Business Overview
15.2.
Product Offerings
15.3.
Recent Developments
15.4.
Financials (As
Reported)
15.5.
Key Personnel
15.5.1. Astellas Pharma Inc.
15.5.2. Novartis International AG
15.5.3. GlaxoSmithKline plc
15.5.4. Pfizer Inc.
15.5.5. Merck Co. & Inc.
15.5.6. F.Hoffmann-La Roche Ltd.
15.5.7. Toyama Chemical Co., Ltd.
15.5.8. Sanofi Aventis SA
15.5.9. MiddleBrook Pharmaceuticals, Inc.
15.5.10.
Gilead Sciences Inc.
Strategic Recommendations